Conor signs up St Jude to sell DES (drug-eluting stent) in Japan
This article was originally published in Clinica
St Jude Medical has gained access to Conor Medsystems' drug-eluting stent (DES) in a distribution deal covering Japan, Korea, Australia and New Zealand. St Jude has provided its new partner with a $5m loan that will convert into Conor shares "in certain circumstances".
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.